Abstract
As statins may contribute to plaque stabilisation, it is important to evaluate whether these drugs may modify arterial stiffness. In 23 patients, aged 32–70 years, with hypertension and hypercholesterolaemia, a double-blind randomised study vs placebo was performed to evaluate whether atorvastatin was able to modify aortic stiffness, measured from aortic pulse wave velocity (PWV), after a 12-week treatment. The results revealed that atorvastatin did not change blood pressure, significantly lowered (P<0.003; <0.002) plasma total and LDL cholesterol, and increased aortic PWV by +8% (vs −2% under placebo) (P⩽0.05). The percentage changes in plasma total and LDL cholesterol and in PWV were significantly and negatively correlated, independent of blood pressure level. The finding of increased aortic PWV after 12-week statin treatment agrees with studies in monkeys, indicating that, at the early phase of hypolipidaemic diet but not later, aortic PWV increases transiently as a consequence of the significant reduction of lipid vascular content. In conclusion, the present results support the possibility that statins might contribute to a change in arterial stiffness independent of blood pressure level, and suggest that long-term studies in humans are needed to evaluate the contribution of arterial elasticity to statin-induced vascular remodelling.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Safar ME . Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors Curr Opin Nephrol Hypertens 2001 10: 257–261
Guerin AP et al. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure Circulation 2001 103: 987–992
Safar ME, London GM . The arterial system in human hypertension In: Swales JD (ed) Textbook of Hypertension Blackwell Scientific: London 1999 pp. 85–102
Dart AM et al. Aortic distensibility in patients with isolated hypercholesterolemia, coronary artery disease, or cardiac transplant Lancet 1991 338: 270–273
Cameron JD, Jennings GL, Dart AM . The relationship between arterial compliance, age, blood pressure and serum lipid levels J Hypertens 1995 13: 1718–1723
Leeson CPM et al. Cholesterol and arterial distensibility in the first decade of life. A population-based study Circulation 2000 101: 1533–1538
Aggoun Y et al. Arterial mechanical changes in children with familial hypercholesterolemia Arterio-scler Thromb Vasc Biol 2000 20: 2070–2075
Steinberg HO et al. Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans Circulation 1997 96: 3287–3293
Egashira K et al. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia Circulation 1994 89: 2519–2524
Aikawa M, Rabbin E, Okada Y . Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization Circulation 1998 97: 2433–2444
Crisby M et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metallproteinases, and cell death in human carotid plaques. K implications for plaque stabilization Circulation 2001 103: 926–933
Fukumoto Y et al. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of Watanabe heritable hyperlipidemic rabbits Circulation 2001 103: 993–999
Muramatsu J, Kobayashi A, Hasegawa N, Yokouchi S . Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatin Atherosclerosis 1997 130: 189–182
Kool M et al. Does lowering of cholesterol levels influence functional properties of large arteries? Eur J Clin Pharmacol 1995 48: 217–223
Giannattasio C et al. Combined effects of hypertension and hypercholesterolemia on radial artery function Hypertension 1997 29: 583–586
Kjekshus J, Persen T, Tobert J . Lipid lowering therapy for patients with or at risk for coronary artery disease Curr Opin Cardiol 1996 11: 418–427
Watts G, Burke V . Lipid-lowering trials in the primary and secondary prevention of coronary heart disease: new evidence, implications and outstanding issues Curr Opin Lipidol 1996 7: 341–355
Asmar R et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application studies Hypertension 1995 26: 485–490
Topouchian et al. Changes in arterial structure and function under trandolapril–verapamil combination in hypertension Stroke 1999 30: 1056–1064
Wilkinson IB et al. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis J Hypertens 1998 16: 2079–2084
Benthin M, Dahl P, Ruzicka R, Lindström K . Calculation of pulse wave velocity using cross correlation: effects of reflexes in the arterial tree Ultrasound Med Biol 1991 5: 461–469
Liang Y-L et al. Non-invasive measurements of arterial structure and function: repeatability, interrelationships and trial sample size Clin Sci 1998 95: 669–679
Glorioso N et al. Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia Hypertension 1999 34: 128 1–1286
Farrar DJ, Bond MG, Riley WA, Sawyer JK . Anatomic correlates of aortic pulse wave velocity and carotid artery elasticity during atherosclerosis progression and regression in monkeys Circulation 1991 83: 1754–1763
Farrar DJ, Bond MG, Sawyer JK, Greene HD . Pulse wave velocity and morphological changes associated with early atherosclerosis progression in the aortas of cynomolgus monkeys Cardiovasc Res 1984 18: 107–118
Farrar DJ, Green D, Wagnere WD, Bond DC . Reduction in pulse wave velocity and improvement of aortic distensibility accompanying regression of atherosclerosis in the rhesus monkey Circ Res 1980 47: 425–432
Farrar DJ et al. Aortic pulse wave velocity, elasticity and composition in a non-human primate model of atherosclerosis Circ Res 1978 43: 52–62
Corti R et al. Effects of lipid-lowering by simvastatine on human atherosclerotic lesions. A longitudinal study by high-resolution, noninvasive magnetic resonance imaging Circulation 2001 104: 249–252
Giannattasio C, Mangoni AA, Faila M . Impaired radial artery compliance in normotensive subjects with familial hypercholesterolemia Atherosclerosis 1996 124: 249–260
Pfeffer MA, Sacks FM, Moye LA . CARE Investigators. Cholesterol and recurrent events: a secondary prevention trial for normolipidemic patients Am J Cardiol 1995 76: 98C–106C
Scandinavian Simvastin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastin Survival Study (4s) Lancet 1994 344: 1383–1389
Acknowledgements
This study was performed with the help of INSERM, Association Claude Bernard and GPH-CV. We thank Mrs Anne Safar for her skilful technical help.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Raison, J., Rudnichi, A. & Safar, M. Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: a preliminary study. J Hum Hypertens 16, 705–710 (2002). https://doi.org/10.1038/sj.jhh.1001470
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001470
Keywords
This article is cited by
-
Atorvastatin can delay arterial stiffness progression in hemodialysis patients
International Urology and Nephrology (2022)
-
Cardiovascular Calcifications in Old Age: Mechanisms and Clinical Implications
Current Translational Geriatrics and Experimental Gerontology Reports (2013)
-
Low-dose atorvastatin reduces ambulatory blood pressure in patients with mild hypertension and hypercholesterolaemia: a double-blind, randomized, placebo-controlled study
Journal of Human Hypertension (2012)
-
Effects of fluvastatin on insulin resistance and cardiac morphology in hypertensive patients
Journal of Human Hypertension (2011)
-
Arterial stiffening in hypertension: beyond blood pressure levels
Journal of Human Hypertension (2010)